Ms. Geffner-Atiya holds a Bachelor of Science degree from the State University of New York at Brockport. In her new role, she will oversee regulatory compliance, quality assurance, and global ...

Fourth quarter revenues increased 116% to $91.1 million versus fourth quarter of 2023Full year revenues increased 473% to $290.5 million versus ...

Of all the risks associated with pharmaceuticals and medical devices, controlling contamination is one of the most important and difficult challenges. Relational risk analysis (ReRA) can help.

Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...

According to a press release from Saladax, Geffner-Atiya has successfully led regulatory strategies across large blue-chip corporations and pioneering start-ups, securing clearances under IVDRR, 510 ...

Imricor’s second-generation Vision-MR Ablation Catheter has received CE mark certification under new, more-stringent, European Medical Device Regulation. ... Read More The post Imricor’s ...